This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 92/2/169    most recent 01.RES.0000051885.70159.12v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Lewinski, D. Articles by Pieske, B. Search for Related Content PubMed PubMed Citation Articles by von Lewinski, D. Articles by Pieske, B. Related Collections Contractile function Calcium cycling/excitation-contraction coupling Cell signalling/signal transduction Growth factors/cytokines Heart failure - basic studies

(Circulation Research. 2003;92:169.)
© 2003 American Heart Association, Inc.

Integrative Physiology

Insulin-Like Growth Factor-1 Exerts Ca²⁺-Dependent Positive Inotropic Effects in Failing Human Myocardium

Dirk von Lewinski, Kerstin Voß, Swen Hülsmann, Harald Kögler, Burkert Pieske

From the Abteilung Kardiologie und Pneumologie (D.v.L., K.V., H.K., B.P.) and Abteilung Neuro- und Sinnesphysiologie (S.H.), Georg-August-Universität Göttingen, Germany.

Correspondence to Prof Dr Burkert Pieske, Abteilung Kardiologie und Pneumologie, Georg-August-Universität Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany. E-mail pieske{at}med.uni-goettingen.de

Myocardial generation of insulin-like growth factor-1 (IGF-1) is altered in hypertrophy and heart failure, but there are no reports on acute functional effects of IGF-1 in human cardiac muscle. We examined inotropic responses and signal transduction mechanisms of IGF-1 in human myocardium. Experiments were performed in isolated trabeculae or cardiomyocytes from 46 end-stage failing hearts. The effect of IGF-1 (0.001 to 0.2 µmol/L) on isometric twitch force (37°C, 1 Hz), intracellular Ca²⁺ transients (aequorin method), sarcoplasmic reticulum (SR) Ca²⁺ content (rapid cooling contractures), L-type Ca²⁺ current (whole-cell voltage clamp), and cAMP concentrations was assessed. In addition, the effects of blocking IGF-1 receptors, phosphoinositide 3-kinase (PI3-kinase), protein kinase C (PKC), or transsarcolemmal Ca²⁺ entry were tested. IGF-1 exerted concentration-dependent positive inotropic effects (twitch force increased to maximally 133±4% of baseline values at 0.1 µmol/L; P<0.05). The IGF-1 receptor antibody IR3 or the PI3-kinase inhibitor wortmannin prevented the functional effects. The inotropic response was paralleled by increases in Ca²⁺ transients and SR Ca²⁺ content. IGF-1 (0.1 µmol/L) increased L-type Ca²⁺ current amplitude by 24±7% (P<0.05). Blockade of SR function did not affect the inotropic response to IGF-1. In contrast, L-type Ca²⁺ channel blockade with diltiazem partially prevented (50%) the inotropic response to IGF-1. Inhibition of PKC (GF109203X), Na⁺-H⁺ exchange (HOE642), or reverse-mode Na⁺-Ca²⁺ exchange (KB-R7943) reduced the response to IGF-1 by 60% to 70%. IGF-1 exerts Ca²⁺-dependent positive inotropic effects through activation of IGF-1 receptors and a PI3-kinase-dependent pathway in failing human myocardium. The increased [Ca²⁺]_i with IGF-1 originates from both enhanced L-type Ca²⁺ currents and enhanced Na⁺-H⁺ exchange-dependent reverse-mode Na⁺-Ca²⁺ exchange. These nongenomic functional effects of IGF-1 may be of clinical relevance.

Key Words: insulin-like growth factor-1 • functional effects • Ca²⁺ handling • heart failure • human myocardium

This article has been cited by other articles:

				Z. Lu, Y.-P. Jiang, X.-H. Xu, L. M. Ballou, I. S. Cohen, and R. Z. Lin Decreased L-Type Ca2+ Current in Cardiac Myocytes of Type 1 Diabetic Akita Mice Due to Reduced Phosphatidylinositol 3-Kinase Signaling Diabetes, November 1, 2007; 56(11): 2780 - 2789. [Abstract] [Full Text] [PDF]

				P. G. Laustsen, S. J. Russell, L. Cui, A. Entingh-Pearsall, M. Holzenberger, R. Liao, and C. R. Kahn Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function Mol. Cell. Biol., March 1, 2007; 27(5): 1649 - 1664. [Abstract] [Full Text] [PDF]

				I. Shiojima and K. Walsh Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway Genes & Dev., December 15, 2006; 20(24): 3347 - 3365. [Abstract] [Full Text] [PDF]

				T. J. Kamp and N. Chiamvimonvat Mission Impossible: IGF-1 and PTEN Specifically "Akt"ing on Cardiac L-Type Ca2+ Channels Circ. Res., June 9, 2006; 98(11): 1349 - 1351. [Full Text] [PDF]

				H. Sun, B.-G. Kerfant, D. Zhao, M. G. Trivieri, G. Y. Oudit, J. M. Penninger, and P. H. Backx Insulin-Like Growth Factor-1 and PTEN Deletion Enhance Cardiac L-Type Ca2+ Currents via Increased PI3K{alpha}/PKB Signaling Circ. Res., June 9, 2006; 98(11): 1390 - 1397. [Abstract] [Full Text] [PDF]

				M. S. Guerra, R. Roncon-Albuquerque Jr, A. P. Lourenco, I. Falcao-Pires, P. Cibrao-Coutinho, and A. F. Leite-Moreira Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat Exp Physiol, March 1, 2006; 91(2): 473 - 480. [Abstract] [Full Text] [PDF]

				N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy Circulation, August 23, 2005; 112(8): 1128 - 1135. [Abstract] [Full Text] [PDF]

				F. Dong, L. B. Esberg, Z. K. Roughead, J. Ren, and J. T. Saari Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H78 - H84. [Abstract] [Full Text] [PDF]

				D. von Lewinski, S. Bruns, S. Walther, H. Kogler, and B. Pieske Insulin Causes [Ca2+]i-Dependent and [Ca2+]i-Independent Positive Inotropic Effects in Failing Human Myocardium Circulation, May 24, 2005; 111(20): 2588 - 2595. [Abstract] [Full Text] [PDF]

				D. B. McElhinney, S. D. Colan, A. M. Moran, D. Wypij, M. Lin, J. A. Majzoub, E. C. Crawford, J. M. Bartlett, E. A. McGrath, and J. W. Newburger Recombinant Human Growth Hormone Treatment for Dilated Cardiomyopathy in Children Pediatrics, October 1, 2004; 114(4): e452 - e458. [Abstract] [Full Text] [PDF]

				J. C. Chachques, F. Duarte, B. Cattadori, A. Shafy, N. Lila, G. Chatellier, J.-N. Fabiani, and A. F. Carpentier Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 245 - 253. [Abstract] [Full Text] [PDF]

				H. Sun, G. Y. Oudit, R. J. Ramirez, D. Costantini, and P. H. Backx The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents Cardiovasc Res, June 1, 2004; 62(3): 509 - 520. [Abstract] [Full Text] [PDF]

				J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793. [Abstract] [Full Text] [PDF]

				S. A. McDowell, E. McCall, W. F. Matter, T. B. Estridge, and C. J. Vlahos Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H796 - H805. [Abstract] [Full Text] [PDF]